Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Niraparib Market Growth 2022-2028

  • LP 4768424
  • 72 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Niraparib will have significant change from previous year. According to our (LP Information) latest study, the global Niraparib market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Niraparib market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Niraparib market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Niraparib market, reaching US$ million by the year 2028. As for the Europe Niraparib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Niraparib players cover TESARO, Everest Pharmaceuticals Limited, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Niraparib market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

100mg*30 Capsules

100mg*60 Capsules

100mg*90 Capsules

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Recurrent Epithelial Ovarian Cancer

Fallopian Tube Cancer

Primary Peritoneal Cancer

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

TESARO

Everest Pharmaceuticals Limited

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Niraparib Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Niraparib by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Niraparib by Country/Region, 2017, 2022 & 2028

2.2 Niraparib Segment by Type

2.2.1 100mg*30 Capsules

2.2.2 100mg*60 Capsules

2.2.3 100mg*90 Capsules

2.3 Niraparib Sales by Type

2.3.1 Global Niraparib Sales Market Share by Type (2017-2022)

2.3.2 Global Niraparib Revenue and Market Share by Type (2017-2022)

2.3.3 Global Niraparib Sale Price by Type (2017-2022)

2.4 Niraparib Segment by Application

2.4.1 Recurrent Epithelial Ovarian Cancer

2.4.2 Fallopian Tube Cancer

2.4.3 Primary Peritoneal Cancer

2.4.4 Other

2.5 Niraparib Sales by Application

2.5.1 Global Niraparib Sale Market Share by Application (2017-2022)

2.5.2 Global Niraparib Revenue and Market Share by Application (2017-2022)

2.5.3 Global Niraparib Sale Price by Application (2017-2022)

3 Global Niraparib by Company

3.1 Global Niraparib Breakdown Data by Company

3.1.1 Global Niraparib Annual Sales by Company (2020-2022)

3.1.2 Global Niraparib Sales Market Share by Company (2020-2022)

3.2 Global Niraparib Annual Revenue by Company (2020-2022)

3.2.1 Global Niraparib Revenue by Company (2020-2022)

3.2.2 Global Niraparib Revenue Market Share by Company (2020-2022)

3.3 Global Niraparib Sale Price by Company

3.4 Key Manufacturers Niraparib Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Niraparib Product Location Distribution

3.4.2 Players Niraparib Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Niraparib by Geographic Region

4.1 World Historic Niraparib Market Size by Geographic Region (2017-2022)

4.1.1 Global Niraparib Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Niraparib Annual Revenue by Geographic Region

4.2 World Historic Niraparib Market Size by Country/Region (2017-2022)

4.2.1 Global Niraparib Annual Sales by Country/Region (2017-2022)

4.2.2 Global Niraparib Annual Revenue by Country/Region

4.3 Americas Niraparib Sales Growth

4.4 APAC Niraparib Sales Growth

4.5 Europe Niraparib Sales Growth

4.6 Middle East & Africa Niraparib Sales Growth

5 Americas

5.1 Americas Niraparib Sales by Country

5.1.1 Americas Niraparib Sales by Country (2017-2022)

5.1.2 Americas Niraparib Revenue by Country (2017-2022)

5.2 Americas Niraparib Sales by Type

5.3 Americas Niraparib Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Niraparib Sales by Region

6.1.1 APAC Niraparib Sales by Region (2017-2022)

6.1.2 APAC Niraparib Revenue by Region (2017-2022)

6.2 APAC Niraparib Sales by Type

6.3 APAC Niraparib Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Niraparib by Country

7.1.1 Europe Niraparib Sales by Country (2017-2022)

7.1.2 Europe Niraparib Revenue by Country (2017-2022)

7.2 Europe Niraparib Sales by Type

7.3 Europe Niraparib Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Niraparib by Country

8.1.1 Middle East & Africa Niraparib Sales by Country (2017-2022)

8.1.2 Middle East & Africa Niraparib Revenue by Country (2017-2022)

8.2 Middle East & Africa Niraparib Sales by Type

8.3 Middle East & Africa Niraparib Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Niraparib

10.3 Manufacturing Process Analysis of Niraparib

10.4 Industry Chain Structure of Niraparib

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Niraparib Distributors

11.3 Niraparib Customer

12 World Forecast Review for Niraparib by Geographic Region

12.1 Global Niraparib Market Size Forecast by Region

12.1.1 Global Niraparib Forecast by Region (2023-2028)

12.1.2 Global Niraparib Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Niraparib Forecast by Type

12.7 Global Niraparib Forecast by Application

13 Key Players Analysis

13.1 TESARO

13.1.1 TESARO Company Information

13.1.2 TESARO Niraparib Product Offered

13.1.3 TESARO Niraparib Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 TESARO Main Business Overview

13.1.5 TESARO Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Niraparib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Niraparib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 100mg*30 Capsules

Table 4. Major Players of 100mg*60 Capsules

Table 5. Major Players of 100mg*90 Capsules

Table 6. Global Niraparib Sales by Type (2017-2022) & (K Pcs)

Table 7. Global Niraparib Sales Market Share by Type (2017-2022)

Table 8. Global Niraparib Revenue by Type (2017-2022) & ($ million)

Table 9. Global Niraparib Revenue Market Share by Type (2017-2022)

Table 10. Global Niraparib Sale Price by Type (2017-2022) & (USD/Pcs)

Table 11. Global Niraparib Sales by Application (2017-2022) & (K Pcs)

Table 12. Global Niraparib Sales Market Share by Application (2017-2022)

Table 13. Global Niraparib Revenue by Application (2017-2022)

Table 14. Global Niraparib Revenue Market Share by Application (2017-2022)

Table 15. Global Niraparib Sale Price by Application (2017-2022) & (USD/Pcs)

Table 16. Global Niraparib Sales by Company (2020-2022) & (K Pcs)

Table 17. Global Niraparib Sales Market Share by Company (2020-2022)

Table 18. Global Niraparib Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Niraparib Revenue Market Share by Company (2020-2022)

Table 20. Global Niraparib Sale Price by Company (2020-2022) & (USD/Pcs)

Table 21. Key Manufacturers Niraparib Producing Area Distribution and Sales Area

Table 22. Players Niraparib Products Offered

Table 23. Niraparib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Niraparib Sales by Geographic Region (2017-2022) & (K Pcs)

Table 27. Global Niraparib Sales Market Share Geographic Region (2017-2022)

Table 28. Global Niraparib Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Niraparib Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Niraparib Sales by Country/Region (2017-2022) & (K Pcs)

Table 31. Global Niraparib Sales Market Share by Country/Region (2017-2022)

Table 32. Global Niraparib Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Niraparib Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Niraparib Sales by Country (2017-2022) & (K Pcs)

Table 35. Americas Niraparib Sales Market Share by Country (2017-2022)

Table 36. Americas Niraparib Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Niraparib Revenue Market Share by Country (2017-2022)

Table 38. Americas Niraparib Sales by Type (2017-2022) & (K Pcs)

Table 39. Americas Niraparib Sales Market Share by Type (2017-2022)

Table 40. Americas Niraparib Sales by Application (2017-2022) & (K Pcs)

Table 41. Americas Niraparib Sales Market Share by Application (2017-2022)

Table 42. APAC Niraparib Sales by Region (2017-2022) & (K Pcs)

Table 43. APAC Niraparib Sales Market Share by Region (2017-2022)

Table 44. APAC Niraparib Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Niraparib Revenue Market Share by Region (2017-2022)

Table 46. APAC Niraparib Sales by Type (2017-2022) & (K Pcs)

Table 47. APAC Niraparib Sales Market Share by Type (2017-2022)

Table 48. APAC Niraparib Sales by Application (2017-2022) & (K Pcs)

Table 49. APAC Niraparib Sales Market Share by Application (2017-2022)

Table 50. Europe Niraparib Sales by Country (2017-2022) & (K Pcs)

Table 51. Europe Niraparib Sales Market Share by Country (2017-2022)

Table 52. Europe Niraparib Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Niraparib Revenue Market Share by Country (2017-2022)

Table 54. Europe Niraparib Sales by Type (2017-2022) & (K Pcs)

Table 55. Europe Niraparib Sales Market Share by Type (2017-2022)

Table 56. Europe Niraparib Sales by Application (2017-2022) & (K Pcs)

Table 57. Europe Niraparib Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Niraparib Sales by Country (2017-2022) & (K Pcs)

Table 59. Middle East & Africa Niraparib Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Niraparib Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Niraparib Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Niraparib Sales by Type (2017-2022) & (K Pcs)

Table 63. Middle East & Africa Niraparib Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Niraparib Sales by Application (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Niraparib Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Niraparib

Table 67. Key Market Challenges & Risks of Niraparib

Table 68. Key Industry Trends of Niraparib

Table 69. Niraparib Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Niraparib Distributors List

Table 72. Niraparib Customer List

Table 73. Global Niraparib Sales Forecast by Region (2023-2028) & (K Pcs)

Table 74. Global Niraparib Sales Market Forecast by Region

Table 75. Global Niraparib Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Niraparib Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Niraparib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 78. Americas Niraparib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Niraparib Sales Forecast by Region (2023-2028) & (K Pcs)

Table 80. APAC Niraparib Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Niraparib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 82. Europe Niraparib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Niraparib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Middle East & Africa Niraparib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Niraparib Sales Forecast by Type (2023-2028) & (K Pcs)

Table 86. Global Niraparib Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Niraparib Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Niraparib Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Niraparib Sales Forecast by Application (2023-2028) & (K Pcs)

Table 90. Global Niraparib Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Niraparib Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Niraparib Revenue Market Share Forecast by Application (2023-2028)

Table 93. TESARO Basic Information, Niraparib Manufacturing Base, Sales Area and Its Competitors

Table 94. TESARO Niraparib Product Offered

Table 95. TESARO Niraparib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 96. TESARO Main Business

Table 97. TESARO Latest Developments

Table 98. Everest Pharmaceuticals Limited Basic Information, Niraparib Manufacturing Base, Sales Area and Its Competitors

Table 99. Everest Pharmaceuticals Limited Niraparib Product Offered

Table 100. Everest Pharmaceuticals Limited Niraparib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 101. Everest Pharmaceuticals Limited Main Business

Table 102. Everest Pharmaceuticals Limited Latest Developments

List of Figures

Figure 1. Picture of Niraparib

Figure 2. Niraparib Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Niraparib Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Niraparib Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Niraparib Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 100mg*30 Capsules

Figure 10. Product Picture of 100mg*60 Capsules

Figure 11. Product Picture of 100mg*90 Capsules

Figure 12. Global Niraparib Sales Market Share by Type in 2021

Figure 13. Global Niraparib Revenue Market Share by Type (2017-2022)

Figure 14. Niraparib Consumed in Recurrent Epithelial Ovarian Cancer

Figure 15. Global Niraparib Market: Recurrent Epithelial Ovarian Cancer (2017-2022) & (K Pcs)

Figure 16. Niraparib Consumed in Fallopian Tube Cancer

Figure 17. Global Niraparib Market: Fallopian Tube Cancer (2017-2022) & (K Pcs)

Figure 18. Niraparib Consumed in Primary Peritoneal Cancer

Figure 19. Global Niraparib Market: Primary Peritoneal Cancer (2017-2022) & (K Pcs)

Figure 20. Niraparib Consumed in Other

Figure 21. Global Niraparib Market: Other (2017-2022) & (K Pcs)

Figure 22. Global Niraparib Sales Market Share by Application (2017-2022)

Figure 23. Global Niraparib Revenue Market Share by Application in 2021

Figure 24. Niraparib Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Niraparib Revenue Market Share by Company in 2021

Figure 26. Global Niraparib Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Niraparib Revenue Market Share by Geographic Region in 2021

Figure 28. Global Niraparib Sales Market Share by Region (2017-2022)

Figure 29. Global Niraparib Revenue Market Share by Country/Region in 2021

Figure 30. Americas Niraparib Sales 2017-2022 (K Pcs)

Figure 31. Americas Niraparib Revenue 2017-2022 ($ Millions)

Figure 32. APAC Niraparib Sales 2017-2022 (K Pcs)

Figure 33. APAC Niraparib Revenue 2017-2022 ($ Millions)

Figure 34. Europe Niraparib Sales 2017-2022 (K Pcs)

Figure 35. Europe Niraparib Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Niraparib Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa Niraparib Revenue 2017-2022 ($ Millions)

Figure 38. Americas Niraparib Sales Market Share by Country in 2021

Figure 39. Americas Niraparib Revenue Market Share by Country in 2021

Figure 40. United States Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Niraparib Sales Market Share by Region in 2021

Figure 45. APAC Niraparib Revenue Market Share by Regions in 2021

Figure 46. China Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Niraparib Sales Market Share by Country in 2021

Figure 53. Europe Niraparib Revenue Market Share by Country in 2021

Figure 54. Germany Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Niraparib Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Niraparib Revenue Market Share by Country in 2021

Figure 61. Egypt Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Niraparib Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Niraparib in 2021

Figure 67. Manufacturing Process Analysis of Niraparib

Figure 68. Industry Chain Structure of Niraparib

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390